The ARNA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARNA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARNA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARNA Detailed Price Forecast - CNN Money||View ARNA Detailed Summary - Google Finance|
|View ARNA Detailed Summary - Yahoo! Finance||View ARNA Stock Research & Analysis - Zacks.com|
|View ARNA Trends & Analysis - Trade-Ideas||View ARNA Major Holders - Barrons|
|View ARNA Call Transcripts - NASDAQ||View ARNA Breaking News & Analysis - Seeking Alpha|
|View ARNA Annual Report - CompanySpotlight.com||View ARNA OTC Short Report - OTCShortReport.com|
|View ARNA Fundamentals - TradeKing||View ARNA SEC Filings - Bar Chart|
|View Historical Prices for ARNA - The WSJ||View Performance/Total Return for ARNA - Morningstar|
|View the Analyst Estimates for ARNA - MarketWatch||View the Earnings History for ARNA - CNBC|
|View the ARNA Earnings - StockMarketWatch||View ARNA Buy or Sell Recommendations - MacroAxis|
|View the ARNA Bullish Patterns - American Bulls||View ARNA Short Pain Metrics - ShortPainBot.com|
|View ARNA Stock Mentions - StockTwits||View ARNA Stock Mentions - PennyStockTweets|
|View ARNA Stock Mentions - Twitter||View ARNA Investment Forum News - Investor Hub|
|View ARNA Stock Mentions - Yahoo! Message Board||View ARNA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARNA - SECform4.com||View Insider Transactions for ARNA - Insider Cow|
|View ARNA Major Holdings Summary - CNBC||View Insider Disclosure for ARNA - OTC Markets|
|View Insider Transactions for ARNA - Yahoo! Finance||View Institutional Holdings for ARNA - NASDAQ|
|View ARNA Stock Insight & Charts - FinViz.com||View ARNA Investment Charts - StockCharts.com|
|View ARNA Stock Overview & Charts - BarChart||View ARNA User Generated Charts - Trading View|
SAN DIEGO, June 17, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that the first subject has been dosed in ELEVATE UC 52, the first of two pivotal trials within the Phase 3 ELEVATE UC registrational program evaluating etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis (UC). ELEVATE UC 52 is a treat-through trial with a 12-week induction period followed by 40 weeks of maintenance.
Did Hedge Funds Drop The Ball On Arena Pharmaceuticals, Inc. (ARNA)
Posted on Friday June 14, 2019
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT
Posted on Thursday June 13, 2019
Q1 2019 Arena Pharmaceuticals Inc Earnings Call
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
Posted on Thursday June 13, 2019
SAN DIEGO, June 13, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the JMP Securities Life Sciences Conference on Wednesday, June 19, 2019, at 1:30 PM EDT. A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. Arena Pharmaceuticals is driven to deliver novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally.